Iguana Healthcare Management’s Epizyme, Inc EPZM Stock Holding History

Iguana Healthcare Management’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-75,000	Closed	-$1.13M	–	80
2017 Q2	$1.13M	Hold	75,000	–	–	0.64%	47
2017 Q1	$1.29M	Buy	+75,000	New	+$999K	0.64%	49
2016 Q4	–	Sell	-150,000	Closed	-$1.48M	–	84
2016 Q3	$1.48M	Sell	150,000 -50,000	-25%	-$456K	0.26%	73
2016 Q2	$2.05M	Buy	+200,000	New	+$2.23M	0.83%	38
2015 Q4	–	Sell	-110,000	Closed	-$1.42M	–	88
2015 Q3	$1.42M	Buy	110,000 +45,000	+69%	+$908K	0.56%	48
2015 Q2	$1.56M	Buy	+65,000	New	+$1.25M	0.49%	49

Other funds holding EPZM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Iguana Healthcare Management's EPZM Position: Q3 2017 in Review

Iguana Healthcare Management sold out of Epizyme, Inc (EPZM) in Q3 2017, closing a stake of 75,000 shares — an estimated $1.13M sold.

Iguana Healthcare Management first reported a position in EPZM in Q2 2015 and held it in 6 quarters. The position peaked at $2.05M in Q2 2016. 104 funds tracked by Wall St. Rank hold EPZM as of Q3 2017.

Iguana Healthcare Management reported no remaining Epizyme, Inc position as of Q3 2017 after selling out during the quarter.
Iguana Healthcare Management sold 75,000 Epizyme, Inc shares in Q3 2017, an estimated $1.13M.
Iguana Healthcare Management first reported a position in Epizyme, Inc in Q2 2015 and held it in 6 quarters.
Iguana Healthcare Management's Epizyme, Inc position peaked at $2.05M in Q2 2016.
104 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2017.

Based on Iguana Healthcare Management's 13F filing for Q3 2017, filed 14 Nov 2017.